Clinical trial recruitment is notoriously difficult. Studies take longer than planned because they can’t find enough eligible patients. Patients who might benefit from trials don’t know about them. Matching patients to trials requires reviewing complex eligibility criteria against detailed medical histories.

AI offers potential solutions. Here’s what’s actually being used and what it means for clinical research in Australia.

The Recruitment Problem

Clinical trial challenges include:

Slow accrual. Most trials fail to recruit on schedule. The median recruitment rate for trials is well below target.

Patient awareness gaps. Many patients who might qualify for trials never learn about them. Information doesn’t reach patients who might benefit.

Eligibility complexity. Trial eligibility criteria can be dozens of conditions. Manually reviewing whether patients qualify is time-consuming and error-prone.

Clinician burden. Busy clinicians may not have time to think about which patients might qualify for which trials.

Geographic barriers. Trials concentrate in major centres. Regional patients have less access.

These problems slow research and limit patient access to potentially beneficial treatments.

AI Applications in Trial Recruitment

Several AI applications address these challenges:

Eligibility Screening

AI that automatically reviews patient records against trial eligibility criteria:

• Natural language processing extracts clinical information from notes
• Structured data from labs, medications, and diagnoses is matched
• Patients are flagged as potentially eligible for specific trials
• Clinicians receive alerts about trial matches for their patients

This shifts work from clinicians to AI, increasing the patients reviewed without increasing clinician burden.

Patient Matching Platforms

Centralised systems where:

• Multiple trials are registered with eligibility criteria
• Patient data is screened against all relevant trials
• Matches are prioritised and presented to research coordinators
• Patients can be approached efficiently across multiple opportunities

These platforms work at institutional or network level, not just individual trials. AI consultants Sydney working in the research space report growing interest in such platforms from larger research-intensive health services.

Patient-Facing Trial Finders

Tools that let patients:

• Search for trials matching their conditions
• Enter their medical information for matching
• Connect with trial sites for specific studies
• Receive notifications when new relevant trials open

Empowering patients to find trials rather than waiting to be found.

Feasibility Assessment

AI that helps trial sponsors:

• Estimate how many eligible patients exist at potential sites
• Predict recruitment rates based on historical patterns
• Identify optimal site selection for efficient recruitment
• Model different eligibility criteria scenarios

Better trial planning leads to faster recruitment.

Australian Context

Clinical trial AI in Australia faces specific considerations:

Research governance. AI for trial recruitment must work within Australian research ethics and governance frameworks. HREC approval, site-specific assessments, and privacy requirements all apply.

Healthcare system structure. The mix of public and private healthcare, state-based health systems, and varied IT infrastructure creates complexity for AI that needs to work across settings.

Registry infrastructure. ANZCTR (Australia New Zealand Clinical Trials Registry) provides trial registration, but integration with AI recruitment systems varies.

Rare disease challenge. Australia’s population means rare disease trials face particular recruitment challenges. AI might help identify the few eligible patients across the country.

Regulatory landscape. TGA and NHMRC requirements for trials, combined with AI governance considerations, require careful navigation.

What’s Working

In Australian practice, I observe:

Major research hospitals are increasingly using AI eligibility screening. Epic and Cerner both offer trial matching features. Some institutions have built custom solutions.

Cancer centres have been early adopters, where trial access is clinically important and eligibility criteria are well-codified.

Commercial trial platforms (like TriNetX and others) are used by some Australian sites and sponsors for feasibility and recruitment support.

Patient-facing trial finders exist (including ANZCTR’s public search) but AI-enhanced patient matching is less developed.

Network approaches are emerging, with some research networks sharing AI recruitment capability across sites.

Implementation Considerations

For organisations implementing trial recruitment AI:

Data Quality Matters

AI matching is only as good as the data it reads. If clinical documentation is incomplete or inconsistent, matching will miss patients.

Ensure:

• Diagnoses are accurately coded
• Relevant clinical information is documented
• Laboratory and investigation results are accessible
• Medication records are complete

Data quality improvement may be prerequisite to AI effectiveness.

Privacy and Consent

Screening patient records for trial eligibility raises privacy considerations:

• Is screening permitted under existing consents?
• How are potential matches approached?
• What data is shared with sponsors?
• How is patient choice protected?

Work with ethics and privacy teams to establish appropriate frameworks.

Clinician Engagement

AI generates matches; clinicians decide whether to approach patients. Clinician buy-in matters:

• Matches should be presented in useful formats
• False positive rates should be tolerable
• Approach pathways should fit clinical workflow
• Clinicians should trust the matching quality

Implementation should involve clinical champions and research coordinators.

Research Coordinator Capacity

More matches are only useful if there’s capacity to act on them:

• Research coordinators still need to confirm eligibility
• Patient discussions and consent take time
• Trial-specific procedures require resources

AI creates opportunities; resources must exist to pursue them.

Outcome Measurement

Track whether AI actually improves recruitment:

• Screening-to-enrolment ratios
• Time to recruitment targets
• Patient awareness and access metrics
• Clinician and coordinator satisfaction

Without measurement, you don’t know if AI is helping.

For organisations developing trial recruitment AI strategies, working with partners who understand both research and AI helps. AI consultants Melbourne and clinical research specialists can advise on integration and implementation.

Equity Considerations

AI trial recruitment could improve or worsen equity:

Potential improvements:

• More systematic screening might find eligible patients who were previously missed
• Regional patients might be identified for remote participation options
• Diversity monitoring could help identify underrepresented groups

Potential risks:

• AI trained on historical data might perpetuate existing patterns of exclusion
• Digital access requirements might exclude some patients
• Complex eligibility criteria might disproportionately exclude disadvantaged groups

Equity should be explicitly considered in AI recruitment design and evaluation.

Looking Forward

Trial recruitment AI will continue developing:

Decentralised trials. As trials become less site-centric, AI will help match patients to trials they can participate in remotely.

Real-world data integration. Linking trial recruitment to broader real-world data sources for better matching and feasibility.

Adaptive eligibility. AI helping to design more inclusive eligibility criteria while maintaining scientific validity.

Patient empowerment. Better tools for patients to find and evaluate trial options.

For Australian clinical research, AI recruitment support isn’t transformative on its own—it doesn’t solve site capacity, regulatory complexity, or funding challenges. But it can meaningfully improve how patients connect with trials, which benefits both research efficiency and patient access.

That’s worth pursuing thoughtfully.

---

Dr. Rebecca Liu is a health informatics specialist and former Chief Clinical Information Officer. She advises healthcare organisations on clinical AI strategy and implementation.